NAMS
Price
$23.60
Change
+$0.21 (+0.90%)
Updated
Jul 25 closing price
Capitalization
2.65B
17 days until earnings call
WXXWY
Price
$7.97
Change
+$0.37 (+4.87%)
Updated
Jul 25 closing price
Capitalization
16.24B
24 days until earnings call
Interact to see
Advertisement

NAMS vs WXXWY

Header iconNAMS vs WXXWY Comparison
Open Charts NAMS vs WXXWYBanner chart's image
NewAmsterdam Pharma
Price$23.60
Change+$0.21 (+0.90%)
Volume$727.62K
Capitalization2.65B
Wuxi Biologics (Cayman)
Price$7.97
Change+$0.37 (+4.87%)
Volume$16.74K
Capitalization16.24B
NAMS vs WXXWY Comparison Chart in %
Loading...
NAMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WXXWY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NAMS vs. WXXWY commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAMS is a Buy and WXXWY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (NAMS: $23.60 vs. WXXWY: $7.97)
Brand notoriety: NAMS and WXXWY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NAMS: 79% vs. WXXWY: 125%
Market capitalization -- NAMS: $2.65B vs. WXXWY: $16.24B
NAMS [@Biotechnology] is valued at $2.65B. WXXWY’s [@Biotechnology] market capitalization is $16.24B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAMS’s FA Score shows that 1 FA rating(s) are green whileWXXWY’s FA Score has 1 green FA rating(s).

  • NAMS’s FA Score: 1 green, 4 red.
  • WXXWY’s FA Score: 1 green, 4 red.
According to our system of comparison, WXXWY is a better buy in the long-term than NAMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAMS’s TA Score shows that 6 TA indicator(s) are bullish while WXXWY’s TA Score has 4 bullish TA indicator(s).

  • NAMS’s TA Score: 6 bullish, 4 bearish.
  • WXXWY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NAMS is a better buy in the short-term than WXXWY.

Price Growth

NAMS (@Biotechnology) experienced а +6.31% price change this week, while WXXWY (@Biotechnology) price change was +9.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

NAMS is expected to report earnings on Nov 17, 2025.

WXXWY is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WXXWY($16.2B) has a higher market cap than NAMS($2.65B). WXXWY YTD gains are higher at: 80.011 vs. NAMS (-8.171).
NAMSWXXWYNAMS / WXXWY
Capitalization2.65B16.2B16%
EBITDA-254.89MN/A-
Gain YTD-8.17180.011-10%
P/E RatioN/A36.58-
Revenue47.1MN/A-
Total Cash808MN/A-
Total Debt389KN/A-
FUNDAMENTALS RATINGS
WXXWY: Fundamental Ratings
WXXWY
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
61
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NAMSWXXWY
RSI
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
41%
Bearish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
47%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
51%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 11 days ago
71%
Bearish Trend 11 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
69%
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
NAMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WXXWY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LCF39.690.19
+0.49%
Touchstone US Large Cap Focused ETF
CLOD34.940.13
+0.38%
Themes Cloud Computing ETF
CHI10.44-0.01
-0.10%
Calamos Convertible Opportunities and Income Fund
PHYD51.83-0.08
-0.15%
Putnam ESG High Yield ETF
XLE87.10-0.33
-0.38%
The Energy Select Sector SPDR® ETF

NAMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAMS has been loosely correlated with QURE. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if NAMS jumps, then QURE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAMS
1D Price
Change %
NAMS100%
+0.90%
QURE - NAMS
57%
Loosely correlated
-0.66%
CRDF - NAMS
44%
Loosely correlated
-4.11%
IRON - NAMS
40%
Loosely correlated
+0.05%
BEAM - NAMS
38%
Loosely correlated
+3.68%
NRIX - NAMS
38%
Loosely correlated
-0.09%
More

WXXWY and

Correlation & Price change

A.I.dvisor indicates that over the last year, WXXWY has been loosely correlated with WXIBF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if WXXWY jumps, then WXIBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WXXWY
1D Price
Change %
WXXWY100%
+4.87%
WXIBF - WXXWY
46%
Loosely correlated
+5.26%
ONC - WXXWY
36%
Loosely correlated
-1.68%
SNBIF - WXXWY
28%
Poorly correlated
N/A
NAMS - WXXWY
23%
Poorly correlated
+0.90%
ZLAB - WXXWY
23%
Poorly correlated
-1.59%
More